SARS-CoV-2感染后新发免疫介导性疾病的风险:系统综述与Meta分析
该系统综述与Meta分析纳入8项分析性观察研究,比较有确诊SARS-CoV-2感染史者与无感染史者新发免疫介导性疾病的风险,排除感染后30天内诊断的病例。对6项研究的13个结局进行Meta分析,暴露组11种疾病风险显著升高,关联范围从系统性硬化症的2.31(95%CI 1.87-2.85)至白塞病的3.71(95%CI 1.18-11.72);吉兰-巴雷综合征和儿童1型糖尿病未见关联证据。
要点
- SARS-CoV-2感染后11种免疫介导性疾病风险显著升高,关联范围2.31至3.71。
- 系统性硬化症关联为2.31(95%CI 1.87-2.85),白塞病为3.71(95%CI 1.18-11.72)。
- 吉兰-巴雷综合征和儿童1型糖尿病与SARS-CoV-2感染无关联证据。
核心结论
- 结果支持SARS-CoV-2感染者发生至少11种所评估免疫介导性疾病的风险更高。
- 作者认为自身免疫是新冠后综合征的标志,未来这些疾病可能增加。
- 作者建议医疗专业人员和利益相关者应基于这些发现优先开展研究和公共卫生监测。
研究设计与样本
- 系统综述与Meta分析,纳入报告确诊SARS-CoV-2感染后免疫介导性疾病、并与无感染史者比较的分析性观察研究。
- 定义39种免疫介导性疾病为感兴趣结局,排除感染后30天内诊断的研究。
- 检索PubMed、EMBASE、CINAHL、Web of Science和Europe PMC。
- 采用随机效应模型和Mantel-Haenszel法合并相对风险。
- 8项研究符合纳入标准,对6项研究的13个结局进行Meta分析。
主要发现
- SARS-CoV-2暴露组相比非暴露组,11种疾病风险显著升高:白塞病、脊柱关节炎、系统性硬化症、系统性红斑狼疮、风湿性多肌痛、银屑病、类风湿关节炎、干燥综合征、成人1型糖尿病、血管炎和炎症性肠病。
- 关联范围从系统性硬化症的2.31(95%CI 1.87-2.85)至白塞病的3.71(95%CI 1.18-11.72)。
- 吉兰-巴雷综合征和儿童1型糖尿病与SARS-CoV-2感染无关联证据。
关键数值与推荐
- 纳入标准:报告确诊SARS-CoV-2感染后免疫介导性疾病、并与无感染史者比较的分析性观察研究。
- 排除标准:包括感染后30天内诊断的研究。
- 结局定义:39种免疫介导性疾病为感兴趣结局。
- 合并方法:随机效应模型和Mantel-Haenszel法合并相对风险。
临床怎么用
- 作者建议医疗专业人员和利益相关者应基于这些发现优先开展研究和公共卫生监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The association between SARS-CoV-2 infection and new onset of immune-mediated diseases is of interest given the conflicting evidence. This study aims to gather evidence and estimate the risk of immune-mediated diseases following SARS-CoV-2 infection. METHODS: Analytical observational studies reporting immune-mediated diseases after confirmed SARS-CoV-2 infection, compared to individuals without infection history, were included. Thirty-nine immune-mediated diseases were defined as outcomes of interest. Studies including diagnosis within the first 30 days post-infection were excluded. PubMed, EMBASE, CINAHL, Web of Science, and Europe PMC were consulted. Relative risks were pooled using a random-effects model and the Mantel-Haenszel method. RESULTS: Eight studies met the eligibility criteria. Meta-analyses were conducted for 13 outcomes of interest from six studies. The SARS-CoV-2 exposed group exhibited significantly higher risks for 11 conditions compared to non-exposed group: Behçet's disease, spondyloarthritis, systemic sclerosis, systemic lupus erythematosus, polymyalgia rheumatica, psoriasis, rheumatoid arthritis, Sjögren's syndrome, type 1 diabetes (in adults), vasculitis, and inflammatory bowel disease. The range of the associations varied between 2.31 (95 % CI: 1.87-2.85) for systemic sclerosis to 3.71 (95 % CI: 1.18-11.72) for Behçet's disease. Guillain-Barré syndrome and type 1 diabetes (in the paediatric population) showed no evidence of association with SARS-CoV-2 infection. CONCLUSION: Our results support a higher risk of developing at least 11 immune-mediated diseases evaluated. As autoimmunity is a hallmark of post-COVID-19 syndrome, an increase in these diseases may be expected in the future. Healthcare professionals and stakeholders should prioritize research and public health surveillance based on these findings.
引用
- Gil AM, Barahona-Correa J, Flórez JB, et al. Risk of new onset of immune-mediated diseases after SARS-CoV-2 infection: A systematic review and meta-analysis. Semin Arthritis Rheum. 2025. PMID: 40812100. doi:10.1016/j.semarthrit.2025.152805
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。